RA0432

antibody from Oursmab
Targeting: ITGAV CD51, MSK8, VNRA, VTNR
Provider product page for RA0432
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0432 - Provider product page
Provider
Oursmab
Product name
Etaracizumab (Biosimilar Reference Antibody) (ITGAVB3)
Antibody type
Monoclonal
Description
Etaracizumab is a humanized monoclonal IgG1 antibody developed as an anti-angiogenic therapy for the treatment of solid tumors. It functions as a selective integrin antagonist, specifically designed to block a key receptor involved in new blood vessel formation (angiogenesis) and tumor cell migration. By binding with high affinity to its target integrin on the surface of proliferating endothelial cells and some tumor cells, etaracizumab inhibits their interaction with extracellular matrix proteins. This blockade disrupts critical signaling pathways necessary for endothelial cell survival, migration, and capillary tube formation, thereby starving the tumor of its blood supply and potentially inhibiting its growth and spread.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
ITGAV protein structure - RA0432 shown in red.